Friday, 3 May 2013

Research a role of interleukin 17 in Repair?

Li Z, Li K, Zhu L, Kan Q, Yan Y, Kumar P, Xu H, Rostami A, Zhang GX. Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation. BMC Immunol. 2013 Apr;14(1):20. [Epub ahead of print]


BACKGROUND. IL-17, a Th17 cell-derived proinflammatory molecule, has been found to play an important role in the pathogenesis of autoimmune diseases, including multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). While IL-17 receptor (IL-17R) is expressed in many immune-related cells, microglia, and astrocytes, it is not known whether IL-17 exerts a direct effect on neural stem cells (NSCs) and oligodendrocytes, thus inducing inflammatory demyelination in the central nervous system.

METHODS:We first detected IL-17 receptor expression in NSCs with immunostaining and real time PCR. We then cultured NSCs with IL-17 and determined NSC proliferation by neurosphere formation capability and cell number count, differentiation by immunostaining neural specific markers, and apoptosis of NSCs by flow cytometry.

RESULTS: NSCs constitutively express IL-17R, and when the IL-17R signal pathway was activated by adding IL-17 to NSC culture medium, the number of NSCs was significantly reduced and their ability to form neurospheres was greatly diminished. IL-17 inhibited NSC proliferation, but did not induce cytotoxicity or apoptosis. IL-17 hampered the differentiation of NSCs into astrocytes and oligodendrocyte precursor cells (OPCs). The effects of IL-17 on NSCs can be partially blocked by p38 MAPK inhibitor.
CONCLUSIONS: IL-17 blocks proliferation of NSCs, resulting in significantly reduced numbers of astrocytes and OPCs. Thus, in addition to its proinflammatory role in the immune system, IL-17 may also play a direct role in blocking remyelination and neural repair in the CNS.


Interleukin 17 (IL-17) is a T cell differentiation factor produced by Th17 T cells thought to drive autoimmunity. In this study it appears that IL-17 stops neural stem cell proliferation and this blocks the development of astrocytes and oligodendrocytes. Therefore the effect of blockade of  IL-17 would be that it blocks relapsing attacks but it could also stimulate repair, or maybe stimulate the formation of an astrocytic scar. Although if the blocker is an antibody it may not do this as not much of it will get in the brain. Blocking IL-17 with antibodies is ongoing in MSers in trials. Will it promote repair?

1 comment:

  1. According to this abstract
    http://clincancerres.aacrjournals.org/content/early/2013/04/24/1078-0432.CCR-13-0042.short

    It seems as if Laquinimod can have a simular action.

    " Targeting IL-17 via specific neutralizing antibodies or a small inhibitory molecule, Laquinimod, significantly decreased M1/M2 ratio and concomitantly suppressed BRONJ-like condition in mice. "

    ReplyDelete

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.